XENE XENON PHARMACEUTICALS
Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · after market close
What 22 analyst firms say about XENON PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
19 rated views · 22 analyst/firm records · 22 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #75 in the index82
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8067
Recent analyst activity · last 90 days
Our tracked history has 14 reports on XENE from 13 analyst firms in the last 90 days (23 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 5 lowered it, 2 left it unchanged and 3 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: SVB Leerink lowered its target from $70.00 (set 8 May 2026) to $60.00 on 8 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Brian Skorney | Buy | 18 Sep 2026 | 90.00 USD |
| Bank of America Securities | Unnamed analyst | Buy | 9 Mar 2026 | — |
| Cantor Fitzgerald | Josh Schimmer | Buy | 10 Mar 2026 | 90.00 USD |
| Deutsche Bank | David Hoang | Hold | 18 Sep 2026 | 46.00 USD |
| Evercore ISI | Cory Kasimov | Buy | 7 Aug 2026 | 80.00 USD |
| Goldman Sachs | Paul K Choi | Buy | 18 Sep 2026 | 75.00 USD |
| Guggenheim | Delma Caiati | Buy | 6 Oct 2026 | 73.00 USD |
| H.C. Wainwright | Douglas Tsao | Buy | 18 Sep 2026 | 74.00 USD · 7 Aug 2026 |
| Jefferies | Andrew Tsai | Buy | 28 Sep 2026 | 90.00 USD |
| JPMorgan | Tessa Romero | Buy | 27 May 2026 | 82.00 USD |
| Leerink Partners | Marc Goodman | Buy | 8 Oct 2026 | 60.00 USD |
| Morgan Stanley | Unnamed analyst | — | 9 Mar 2026 | 97.00 USD |
| Needham | Serge Belanger | Buy | 18 Sep 2026 | 60.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 18 Sep 2026 | 70.00 USD |
| Stifel | Unnamed analyst | — | 10 Feb 2026 | 66.00 USD |
| TD Cowen | Joseph Thome | Buy | 15 Jun 2026 | — |
| Wedbush | Laura Chico | Buy | 18 Sep 2026 | 55.00 USD |
| Weiss Ratings | Unnamed analyst | — | 2 Oct 2026 | — |
| Wells Fargo | Benjamin Burnett | Buy | 18 Sep 2026 | 64.00 USD |
| William Blair | Myles R Minter | Buy | 6 Aug 2026 | — |
| Wolfe Research | Rudy Li | Buy | 21 Sep 2026 | 70.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:43 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.